BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 27202392)

  • 1. Comparing Access to Drugs Through the CDF and by Nice - The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage.
    Macaulay R
    Value Health; 2014 Nov; 17(7):A659-60. PubMed ID: 27202392
    [No Abstract]   [Full Text] [Related]  

  • 2. Access to anticancer drugs: many evidence-based treatments are off-label and unfunded by the Pharmaceutical Benefits Scheme.
    Mellor JD; Van Koeverden P; Yip SW; Thakerar A; Kirsa SW; Michael M
    Intern Med J; 2012 Nov; 42(11):1224-9. PubMed ID: 22372936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting cognitive dysfunctioning in nondemented patients early after stroke.
    Jaillard A; Grand S; Le Bas JF; Hommel M
    Cerebrovasc Dis; 2010; 29(5):415-23. PubMed ID: 20203483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and physical mapping of the cerebellar deficient folia (cdf) locus on mouse chromosome 6.
    Park C; Longo CM; Ackerman SL
    Genomics; 2000 Oct; 69(1):135-8. PubMed ID: 11013084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
    Haw C; Stubbs J
    J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label use in dermatology in Germany: what has changed since 2004.
    Brockmeyer NH; Brucklacher U; Potthoff A; Reich-Schupke S
    J Dtsch Dermatol Ges; 2009 Nov; 7(11):938-45. PubMed ID: 19386019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholinergic neuronal differentiation factor (CDF)/leukemia inhibitory factor (LIF) binds to specific regions of the developing nervous system in vivo.
    Qiu L; Bernd P; Fukada K
    Dev Biol; 1994 Jun; 163(2):516-20. PubMed ID: 8200484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multispectral characterization of tissues encountered during laparoscopic colorectal surgery.
    Schols RM; Dunias P; Wieringa FP; Stassen LP
    Med Eng Phys; 2013 Jul; 35(7):1044-50. PubMed ID: 23391740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA may set stricter criteria for glans cap, intravaginal pouch.
    Contracept Technol Update; 1989 Jun; 10(6):81-2. PubMed ID: 12342314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
    Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
    Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
    Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
    Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vivo evaluations of curcumin and its analog difluorinated curcumin against cisplatin-induced nephrotoxicity.
    Sahin K; Orhan C; Tuzcu M; Muqbil I; Sahin N; Gencoglu H; Guler O; Padhye SB; Sarkar FH; Mohammad RM
    Biol Trace Elem Res; 2014 Feb; 157(2):156-63. PubMed ID: 24415068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phylogenetic and functional analysis of the Cation Diffusion Facilitator (CDF) family: improved signature and prediction of substrate specificity.
    Montanini B; Blaudez D; Jeandroz S; Sanders D; Chalot M
    BMC Genomics; 2007 Apr; 8():107. PubMed ID: 17448255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between off-label use of drug-eluting stents and subsequent stent thrombosis: a case-control analysis.
    Rabinovitz A; Bier DM; Wagman GM; Charlap E; Nazari R; Ghitelman J; Celaj S; Skeif B; Menegus M; Srinivas VS
    J Invasive Cardiol; 2010 Jan; 22(1):15-9. PubMed ID: 20048393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications.
    Shimazawa R; Ikeda M
    Clin Ther; 2012 Oct; 34(10):2104-16. PubMed ID: 23036337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unlicensed and off label usage of some drugs in obstetric practice].
    Bozhinova S; Tsvetkov D
    Akush Ginekol (Sofiia); 2008; 47(5):43-7. PubMed ID: 19227775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Off-label use of antipsychotics: rethinking "off-label".
    Groleger U
    Psychiatr Danub; 2007 Dec; 19(4):350-3. PubMed ID: 18000487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Public financing for off-label use of drugs].
    Hammerman A; Lipschitz Y; Pliskin J; Greenberg D
    Harefuah; 2011 Feb; 150(2):163-7, 204. PubMed ID: 22164947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumer usage patterns of nonprescription histamine2-receptor antagonists.
    Shi CW; Gralnek IM; Dulai GS; Towfigh A; Asch S
    Am J Gastroenterol; 2004 Apr; 99(4):606-10. PubMed ID: 15089889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label use of medicines in paediatric inpatients at an Australian teaching hospital.
    Ballard CD; Peterson GM; Thompson AJ; Beggs SA
    J Paediatr Child Health; 2013 Jan; 49(1):38-42. PubMed ID: 23279160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.